Does Wegovy Have Fewer Side Effects Than Other Weight-Loss Treatments?

You've started Wegovy and the first week feels rough, is that normal?

For a lot of people, the opening weeks of semaglutide are the hardest. Your gut is adjusting to a medicine that deliberately slows gastric emptying and changes appetite signals, and it lets you know. Nausea is the most commonly reported side effect, followed by vomiting, diarrhoea, constipation, burping and indigestion. Tiredness and headaches are also fairly common early on. The NHS semaglutide medicines page notes these effects are usually mild to moderate and tend to resolve as your body adapts. The titration schedule exists partly for this reason: beginning at 0.25mg and stepping up slowly, rather than jumping straight to the 2.4mg maintenance dose, gives your system time to settle. So if the first few days feel uncomfortable, that is recognised and expected, it does not necessarily mean semaglutide is wrong for you. Eating smaller portions, staying well hydrated and avoiding rich or fatty foods during a dose increase are things many people find useful, though your prescriber and the Patient Information Leaflet are the right sources for personal guidance. Read more about managing nausea on Wegovy if that is the symptom giving you the most trouble.

How does Wegovy's side-effect profile compare with other weight-loss medicines?

The honest answer is: broadly similar to other GLP-1 receptor agonists, because the mechanism is shared. Tirzepatide (Mounjaro), which activates both GLP-1 and GIP receptors, produces a comparable GI-led side-effect pattern in clinical trials. The STEP 1 trial, published in the New England Journal of Medicine, reported that most side effects with semaglutide 2.4mg were gastrointestinal and generally transient. The SURMOUNT programme with tirzepatide showed a similar picture. Whether you personally tolerate one better than the other is not something trial averages can predict, it is one of the things worth discussing openly with a prescriber before you decide. There is a fuller side-by-side look at Wegovy's full side-effect list if you want the detail. The broader question of how the two medicines sit relative to each other is covered on the Wegovy overview. Older options like orlistat work through a completely different mechanism and produce different side effects, mainly GI-related but triggered by dietary fat rather than dose changes.

When do side effects need medical attention?

Most side effects from Wegovy are self-limiting and can be managed. Some, though, are signals to act quickly. The MHRA's January 2026 Drug Safety Update specifically flagged acute pancreatitis as an infrequent but serious risk with GLP-1 medicines: if you develop severe stomach pain that does not ease and spreads to your back, with or without vomiting, stop taking the medicine and get medical help the same day, do not wait it out. Other situations that warrant prompt attention include signs of a serious allergic reaction (swelling of the face, lips or throat; difficulty breathing), symptoms of significant dehydration after prolonged vomiting or diarrhoea, and unexplained changes in vision. Gallbladder problems have also been reported, pain in the upper right abdomen, especially after eating, is worth reporting to your GP. If you are unsure whether something is urgent, NHS 111 is a sensible first call. You can also report any suspected reaction through the MHRA Yellow Card scheme, which helps the regulator track safety signals in real-world use. The long-term side effects page addresses what the evidence says about risks beyond the initial titration period. Our prescribers go through your medical history and current medicines before approving any treatment, and our aftercare team is available seven days a week, details on how to reach us are on the contact page.

Does the side-effect picture improve over time?

For most people, yes. GI symptoms tend to peak during the first few weeks at a new dose and then quieten down as the body adjusts. By the time someone reaches their maintenance dose, many people report that the nausea they experienced early on has largely passed. That is not universal (some people continue to experience intermittent GI discomfort throughout treatment) but the pattern of early disruption followed by adaptation is well established in the clinical literature. The question of whether side effects reduce over the course of treatment comes up often, and the short answer is: frequently, though not always. If side effects remain disruptive at any dose, the pace of titration can sometimes be slowed, that is a clinical decision made with your prescriber, not something to manage alone. The cost of treatment is a separate consideration many people want to weigh alongside tolerability; it is covered plainly on that page. If you are weighing up whether Wegovy is the right fit given your health history, the weight-loss treatment overview sets out the options. Our prescribers at nume are happy to talk through any of this as part of a free consultation, no pressure, just a clinical conversation.